Clinimix Injection
Product Images NDC 0338-7013

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Clinimix (NDC 0338-7013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figures 1 (4)

An instructional diagram showing four steps to prepare a room temperature intravenous injection container for use. Steps include laying the container flat and grasping the top corners, rolling to break the peel seal between chambers, mixing by turning the container upside down, and hanging the container while removing the protector and connecting the spike.*

FDA Label Image

Dextrose Hydrous Structural Formula (Image 02)

Instructional diagram showing the proper steps for preparing the CLINIMIX injection. The four-panel illustration demonstrates laying the container flat, rolling to break the peel seal between chambers, mixing by turning the container upside-down multiple times, and hanging the container to access the administration outlet for intravenous use.*

FDA Label Image

Representative Container Label 0338-1132 (Image 03)

Chemical structure of Dextrose Hydrous, USP (d-Glucose monohydrate) showing the molecular arrangement with hydroxyl groups and hydration indicated.*

FDA Label Image

Representative Carton Label 0338-1132 (Image 04)

CLINIMIX 4.25/10 injection label shows a 500 mL IV infusion product containing 4.25% amino acids in 10% dextrose. It is a sulfite-free amino acid and dextrose injection for central line infusion only, with separate injection port chambers for 20% dextrose and 8.5% amino acid solutions. The label lists essential and nonessential amino acid amounts per 100 mL, including leucine, isoleucine, valine, lysine, phenylalanine, histidine, threonine, methionine, tryptophan, alanine, glycine, arginine, proline, serine, and tyrosine, plus electrolytes acetate and chloride. It is manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 0338-1134 (Image 05)

CLINIMIX 4.25/5 sulfite-free injection label showing a 4.25% amino acids in 5% dextrose intravenous solution. The label specifies a 500 mL injection port chamber with 10% dextrose injection USP and a 500 mL outlet port chamber with 8.5% amino acid injection. Manufactured by Baxter Healthcare Corporation, the label lists amino acid and dextrose concentrations, storage instructions, and sterile, single-dose use.*

FDA Label Image

Representative Carton Label 0338-1134 (Image 06)

CLINIMIX 4.25/5 Sulfite-Free Injection label showing 4.25% amino acids in 5% dextrose formulation. It specifies a 1000 mL injection port chamber with 10% dextrose and a 1000 mL outlet port chamber with 8.5% amino acid injection. The label lists amino acid contents and other components per 100 mL and instructions for activation and storage by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 0338-1083 (Image 07)

CLINIMIX 4.25/10 sulfite-free intravenous injection containing 4.25% amino acids in 10% dextrose. This label includes detailed composition per 100 mL of essential and nonessential amino acids and dextrose hydrous. Packaged in a 1000 mL injection port chamber with 20% dextrose injection USP and a 1000 mL outlet port chamber with 8.5% amino acid injection. Labeler is Baxter Healthcare Corporation.*

FDA Label Image

Representative Carton Label 0338-1083 (Image 08)

CLINIMIX 5/15 Sulfite-Free Injection label for 500 mL intravenous injection, containing 5% amino acids and 15% dextrose. The label indicates central line infusion only with separate injection port chambers for 30% dextrose and 10% amino acid solutions. Manufactured by Baxter Healthcare Corporation. The label includes detailed amino acid and dextrose content per 100 mL of admixed solution and storage instructions.*

FDA Label Image

Representative Container Label 0338-1133 (Image 09)

CLINIMIX 5/15 sulfite-free injection, containing 5% amino acids in 15% dextrose, presented in a 1000 mL injection port chamber. The label details essential and nonessential amino acid concentrations per 100 mL, including leucine, isoleucine, lysine, phenylalanine, and others, plus dextrose hydrous USP. It is designed for central line infusion only and includes storage and handling instructions. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Representative Carton Label 0338-1133 (Image 10)

CLINIMIX 5/20 sulfite-free injection label showing a 500 mL intravenous solution with 5% amino acids in 20% dextrose. The label details essential and nonessential amino acid content per 100 mL, including leucine 365 mg, isoleucine 300 mg, and dextrose 20 g. It is for central line infusion only, single dose container, by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 0338-1133 (Image 11)

Label for CLINIMIX 5/20 Injection by Baxter Healthcare Corporation, a sulfite-free intravenous injection containing 5% amino acids in 20% dextrose. The label details infusion instructions, ingredients with amino acid concentrations per 100 mL, storage conditions, and activation instructions. The label specifies a 1000 mL injection port chamber with 40% dextrose and a 1000 mL outlet port chamber with 10% amino acid injection.*

FDA Label Image

Representative Carton Label 0338-1133 (Image 12)

CLINIMIX 6/5 Sulfite-Free Injection, a 1000 mL intravenous injection with 6% amino acids in 5% dextrose. The label details a 400 mL injection port chamber and a 600 mL outlet port chamber, specifying 12.5% dextrose and 10% amino acid injection. Manufactured by Baxter Healthcare Corporation, this product is sterile, single dose, and requires activation and mixing before use.*

FDA Label Image

Representative Container Label 0338-1091 (Image 13)

CLINIMIX 8/10 Sulfite-Free Injection is a sterile intravenous solution containing 8% amino acids in 10% dextrose. The label specifies a 360 mL injection port chamber with 28% dextrose and a 640 mL outlet port chamber with 12.5% amino acid injection, totaling 1000 mL. Essential and nonessential amino acids along with electrolyte content and pH adjustment details are listed. Manufactured by Baxter Healthcare Corporation in Belgium, the label emphasizes central line infusion only and includes storage and activation instructions.*

FDA Label Image

Representative Carton Label 0338-1091 (Image 14)

CLINIMIX 8/10 sulfite-free injection with 8% amino acids in 10% dextrose, for central line infusion only. The label details a 720 mL injection port chamber with 28% dextrose and a 1280 mL outlet port chamber with 12.5% amino acid injection. It includes a comprehensive amino acid content list and instructions to activate seal and mix thoroughly before use. Manufactured by Baxter Healthcare Corporation.*

FDA Label Image

Representative Container Label 0338-1135 (Image 15)

Label for CLINIMIX 8/14, an injection solution containing 8% amino acids and 14% dextrose, for intravenous use with central line infusion only. The label lists detailed amino acid content per 100 mL and instructions to activate seal and mix before use. Manufactured by Baxter Healthcare Corporation, this 1000 mL sterile single dose container is made in Belgium and requires refrigeration after opening.*

FDA Label Image

Representative Carton Label 0338-1135 (Image 16)

Label for CLINIMIX 8/14 sulfite-free injection, containing 8% amino acids in 14% dextrose for central line infusion. The label specifies 720 mL injection port chamber with 39% dextrose and 1280 mL outlet port chamber with 12.5% amino acid injection, totaling 2000 mL after mixing. It lists essential and nonessential amino acid contents per 100 mL, along with acetate and chloride concentrations. Manufactured by Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.